ValueScreener

JPMorgan Income ETF (JPIE)

An exchange-traded fund listed on AMEX. A fund is not a company: it has no filed accounts of its own here, and it is never ranked beside companies. Every figure below is market data, with the day it was supplied.

Price

Last close 44.94 USD on Oct 15, 2026. Market data, supplied Oct 15, 2026.

Weekly closes, Nov 5, 2021 (50.52) to Oct 15, 2026 (44.94). Market data, supplied Oct 16, 2026.

What it costs

Expense ratio0.40%
Assets under management11.13B USD
Net asset value per share44.65 USD
InceptionOct 28, 2021
SponsorJ.P. Morgan
Asset classFixed Income
Holdings the fund reports2,741

Market data, supplied Oct 15, 2026.

What it holds

The largest 25 by weight of the 2,755 holdings in the snapshot of Oct 14, 2026. A fund is marked as a fund, and a holding that is not a company's share (a bond, a bill, cash, an option or a swap) is marked as not a company.

#HoldingWeight
1TBA GNMA2 6.5% 12/34 (not a company)8.11%
2JPMORGAN PRIME MONEY5.94%
3GNMA II MORTPASS 6% 06/56 (not a company)2.30%
4GNMA II 5.5% 09/56 (not a company)1.98%
5GNMA II 6.5% 06/56 (not a company)1.63%
6GNMA II 5.5% 01/56 (not a company)1.50%
7GNMA II MORTPASS 6% 08/56 (not a company)1.37%
8GNMA II 6.5% 07/56 (not a company)1.31%
9OTCBA FINRA CSH AT BROKER1.02%
10UMBS MORTPASS 5.5% 01/56 (not a company)0.99%
11UMBS MORTPASS 6% 11/55 (not a company)0.80%
12TBA GNMA2 SINGLE 6.5% (not a company)0.77%
13UMBS MORTPASS 5.5% 01/56 (not a company)0.70%
14FHLMC STACR FLT 10/500.58%
15UMBS MORTPASS 5.5% 03/56 (not a company)0.56%
16GNMA II 5.5% 08/55 (not a company)0.54%
17GNMA 2026-23 A 4.5% 01/60 (not a company)0.52%
18GNMA II 5.5% 02/55 (not a company)0.50%
19UMBS MORTPASS 6% 10/55 (not a company)0.47%
20UMBS MORTPASS 5.5% 08/56 (not a company)0.45%
21GNMA II 5.5% 04/55 (not a company)0.45%
22GNMA II MORTPASS 6% 10/53 (not a company)0.44%
23CITI ASSET 24.84% 11/32 (not a company)0.43%
24GNMA 2026-16 AC 4% 12/57 (not a company)0.42%
25CITI ASSET 26.03% 09/32 (not a company)0.41%

Market data, supplied Oct 15, 2026.

Sector weights

n/a. Not supplied for this fund.

Country weights

Other78.15%
United States14.75%
Mexico0.66%
Canada0.53%
Argentina0.38%
Ecuador0.38%
Ivory Coast0.33%
United Kingdom0.31%
Colombia0.28%
Egypt0.27%
Pakistan0.25%
South Africa0.23%
Dominican Republic0.21%
Angola0.20%
Kenya0.20%
Netherlands0.18%
Nigeria0.17%
Jordan0.16%
El Salvador0.15%
Cayman Islands0.14%
Congo (Rep. of)0.12%
Suriname0.11%
Benin0.09%
Turkey0.09%
Paraguay0.08%
Peru0.08%
Spain0.08%
Switzerland0.08%
Brazil0.07%
Costa Rica0.07%
Honduras0.07%
Luxembourg0.07%
Bolivia0.06%
Cameroon0.06%
Congo (Dem. Rep. of the)0.06%
Panama0.06%
Sri Lanka0.06%
Bahrain0.05%
Ghana0.05%
Ireland0.05%
Rwanda0.05%
Australia0.04%
Bahamas0.04%
Germany0.04%
Jamaica0.04%
Japan0.04%
Morocco0.04%
Romania0.04%
France0.03%
Gabon0.03%
Serbia0.03%
Barbados0.02%
Chile0.02%
Mongolia0.02%
Montenegro0.02%
Trinidad and Tobago0.02%
Uzbekistan0.02%
Iraq0.01%
Kyrgyzstan0.01%
Singapore0.01%
Zambia0.01%
Italy0.00%
Mauritius0.00%

Market data, supplied Oct 15, 2026.

Look-through value

Earnings yield, P/E and book yield of the holdings taken together: n/a. Look-through figures are not measured for this fund yet.

Once a week, what changed in the filings of US-listed companies, why it can matter to a thesis, and what deserves a closer review. Grounded in filings, not market noise.

Site map
  • Android app coming soon
  • iPhone app coming soon
ValueScreener

Discover companies, research each one to its filings, track what matters, and take your work into your own spreadsheet.

ValueScreener is a trading name of Oliva Real Estate Technologies LLC, a Delaware limited liability company. Legal notices: legal@valuescreener.ai. © 2026 Oliva Real Estate Technologies LLC. All rights reserved.

Risk disclaimer. This service is provided for research and education only. Nothing on it is investment advice, a recommendation, or an offer to buy or sell any security. Capital is at risk, and past performance does not indicate future results. Figures come from filed accounts and may be incomplete, delayed or later restated, so verify a number against the filing before you act on it.